Further research with larger cohorts is necessary to validate these associations and to explore the molecular mechanisms through which VDR polymorphisms influence the progression of cirrhosis and the development of HCC, as well as their impact on clinical outcomes and treatment response. This evidence concerns the gene VDR and hepatocellular carcinoma.